These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 30983178

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A case of a maintenance hemodialysis patient with autosomal dominant polycystic kidney disease who underwent living donor liver transplantation alone due to refractory liver cyst infection.
    Akihisa T, Ino A, Egawa H, Kotera Y, Ariizumi S, Oomori A, Yamashita S, Yamamoto Y, Tsuchiya K, Yamamoto M, Nitta K, Mochizuki T.
    CEN Case Rep; 2018 Nov; 7(2):307-312. PubMed ID: 29956096
    [Abstract] [Full Text] [Related]

  • 4. Octreotide reduces hepatic, renal and breast cystic volume in autosomal-dominant polycystic kidney disease.
    Peces R, Cuesta-López E, Peces C, Pérez-Dueñas V, Vega-Cabrera C, Selgas R.
    Int Urol Nephrol; 2011 Jun; 43(2):565-9. PubMed ID: 20449653
    [Abstract] [Full Text] [Related]

  • 5. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease.
    Takei R, Ubara Y, Hoshino J, Higa Y, Suwabe T, Sogawa Y, Nomura K, Nakanishi S, Sawa N, Katori H, Takemoto F, Hara S, Takaichi K.
    Am J Kidney Dis; 2007 Jun; 49(6):744-52. PubMed ID: 17533017
    [Abstract] [Full Text] [Related]

  • 6. 18F-FDG PET/CT demonstrated renal and hepatic cyst infection in a patient with autosomal dominant polycystic kidney disease.
    Albano D, Bosio G, Bertagna F.
    Nucl Med Rev Cent East Eur; 2016 Jun; 19(B):26-28. PubMed ID: 27813615
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Uncommon cause of chest pain in a renal transplantation patient with autosomal dominant polycystic kidney disease: a case report.
    Rodrigues L, Neves M, Machado S, Sá H, Macário F, Alves R, Mota A, Campos M.
    Transplant Proc; 2012 Oct; 44(8):2507-9. PubMed ID: 23026633
    [Abstract] [Full Text] [Related]

  • 9. Complex liver cysts in Autosomal Dominant Polycystic Kidney Disease.
    Farooq Z, Behzadi AH, Blumenfeld JD, Zhao Y, Prince MR.
    Clin Imaging; 2017 Oct; 46():98-101. PubMed ID: 28768225
    [Abstract] [Full Text] [Related]

  • 10. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
    Kanaan N, Goffin E, Pirson Y, Devuyst O, Hassoun Z.
    Am J Kidney Dis; 2010 May; 55(5):916-22. PubMed ID: 20189277
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of MRI segmentation techniques for measuring liver cyst volumes in autosomal dominant polycystic kidney disease.
    Farooq Z, Behzadi AH, Blumenfeld JD, Zhao Y, Prince MR.
    Clin Imaging; 2018 May; 47():41-46. PubMed ID: 28846875
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.
    Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):64-9. PubMed ID: 17699192
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease.
    Bleeker-Rovers CP, de Sévaux RG, van Hamersvelt HW, Corstens FH, Oyen WJ.
    Am J Kidney Dis; 2003 Jun; 41(6):E18-21. PubMed ID: 12776306
    [Abstract] [Full Text] [Related]

  • 16. Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
    van Aerts RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, Casteleijn NF, Dekker SEI, de Fijter JW, van Gastel M, Gevers TJ, van de Laarschot LFM, Lantinga MA, Losekoot M, Meijer E, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JF, Zietse R, Gansevoort RT, Drenth JPH, DIPAK-1 Investigators.
    Gastroenterology; 2019 Aug; 157(2):481-491.e7. PubMed ID: 31022403
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study.
    Lantinga MA, D'Agnolo HM, Casteleijn NF, de Fijter JW, Meijer E, Messchendorp AL, Peters DJ, Salih M, Spithoven EM, Soonawala D, Visser FW, Wetzels JF, Zietse R, Drenth JP, Gansevoort RT, DIPAK Consortium.
    Drug Saf; 2017 Feb; 40(2):153-167. PubMed ID: 27995519
    [Abstract] [Full Text] [Related]

  • 19. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease.
    Fukasawa H, Kaneko M, Niwa H, Yasuda H, Kumagai H, Furuya R.
    Nephrology (Carlton); 2018 Mar; 23(3):210-216. PubMed ID: 28024168
    [Abstract] [Full Text] [Related]

  • 20. Repetitive Refractory Renal Cyst Infection in Autosomal Dominant Polycystic Kidney Disease for which Renal Transcatheter Arterial Embolization Was Effective in Preventing Recurrence.
    Suwabe T, Oguro M, Ubara Y, Ikuma D, Mizuno H, Hayami N, Yamanouchi M, Sawa N.
    Intern Med; 2021 Mar; 60(20):3261-3265. PubMed ID: 34657906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.